Wendall Wierenga - Sep 1, 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: Director
Signature: /s/ John Faurescu, attorney-in-fact for Dr. Wierenga
Stock symbol: CYTK
Transactions as of: Sep 1, 2022
Transactions value $: -$191,678
Form type: 4
Date filed: 9/1/2022, 06:19 PM
Previous filing: Jul 12, 2022
Next filing: Oct 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Options Exercise	$28.2K	+4.17K	+34.23%	$6.78^*	16.3K	Sep 1, 2022	Direct	F1
transaction	CYTK	Common Stock	Sale	-$220K	-4.17K	-25.5%	$52.79	12.2K	Sep 1, 2022	Direct	F1

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Non-Qualified Stock Option (Right to Buy)	Options Exercise	$0	-4.17K	-100%	$0.00^*	0	Sep 1, 2022	Common Stock	4.17K	$6.78	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.